What antibiotics are used to treat a Staphylococcus (Staph) urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Staphylococcal Urinary Tract Infections

For Staphylococcus UTIs, first-line treatment options include trimethoprim-sulfamethoxazole (TMP-SMX), nitrofurantoin, or penicillinase-resistant penicillins (such as flucloxacillin or dicloxacillin), with the specific choice depending on susceptibility patterns. 1, 2

Antibiotic Selection Based on Staphylococcal Species

Methicillin-Susceptible Staphylococcus aureus (MSSA)

  • Penicillinase-resistant penicillins (flucloxacillin, dicloxacillin) are the antibiotics of choice for serious MSSA infections 2
  • First-generation cephalosporins (cefazolin, cephalothin, cephalexin) are effective alternatives for less serious infections 2
  • Clindamycin is another option for patients with penicillin allergy (except in cases of immediate hypersensitivity) 2
  • TMP-SMX (160/800 mg twice daily) is effective for uncomplicated UTIs caused by susceptible strains 1, 3

Methicillin-Resistant Staphylococcus aureus (MRSA)

  • For serious MRSA infections, parenteral vancomycin is the treatment of choice 2
  • For less serious community-acquired MRSA infections, lincosamides (clindamycin, lincomycin) or TMP-SMX are appropriate 2
  • Linezolid has good anti-staphylococcal activity but should be reserved for patients who fail conventional therapy 2

Staphylococcus saprophyticus

  • Common cause of UTIs, particularly in young women 4
  • Amoxicillin-clavulanate is effective against S. saprophyticus 4
  • Note that S. saprophyticus may have high MICs for ceftriaxone, making this a less optimal choice 4
  • Nitrofurantoin is effective for uncomplicated lower UTIs caused by S. saprophyticus 5

Treatment Duration and Approach

Uncomplicated Lower UTI (Cystitis)

  • 3-5 days of therapy is generally sufficient for uncomplicated cystitis 1
  • For men with staphylococcal UTI, a longer course (7 days) is recommended 1

Complicated UTI or Pyelonephritis

  • 7-14 days of therapy is recommended for complicated UTIs 1
  • For pyelonephritis requiring hospitalization, initial intravenous therapy with appropriate agents should be considered 1
  • Options include fluoroquinolones, aminoglycosides (with or without ampicillin), or extended-spectrum cephalosporins 1

Special Considerations

Biofilm Formation

  • Staphylococcus species are known to form biofilms, which can increase antibiotic resistance 3
  • Biofilm-producing S. aureus strains show higher resistance to nitrofurantoin, tetracycline, erythromycin, and ciprofloxacin 3
  • TMP-SMX and doxycycline may be more effective against biofilm-producing strains 3

Recurrent UTIs

  • For recurrent staphylococcal UTIs, obtain urine cultures to guide therapy 1
  • Consider underlying structural or functional abnormalities of the urinary tract 1
  • Evaluate for the presence of foreign bodies or incomplete voiding 1

Antibiotic Selection Algorithm

  1. Obtain urine culture and sensitivity before starting treatment when possible 1
  2. For empiric therapy of uncomplicated cystitis:
    • First-line: TMP-SMX or nitrofurantoin 1, 5
    • Alternative: First-generation cephalosporins or amoxicillin-clavulanate 5, 4
  3. For suspected or confirmed MRSA UTI:
    • Oral options: TMP-SMX, linezolid, or doxycycline 1, 2
    • Parenteral options: Vancomycin or teicoplanin 2
  4. For complicated UTI or pyelonephritis:
    • Parenteral therapy with vancomycin (for MRSA) or flucloxacillin/cefazolin (for MSSA) 1, 2
    • Consider combination therapy for severe infections 6

Common Pitfalls and Caveats

  • Avoid fluoroquinolones as empiric therapy due to increasing resistance rates unless susceptibility is confirmed 5
  • Do not use cephalosporins in patients with immediate penicillin hypersensitivity (urticaria, angioedema, bronchospasm, or anaphylaxis) 2
  • Avoid using rifampicin or fusidic acid as single agents due to rapid development of resistance 2, 6
  • Remember that S. saprophyticus UTIs are often undertreated with inappropriate empiric therapy 4
  • Do not treat asymptomatic bacteriuria, even with Staphylococcus species 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Staphylococcus saprophyticus: Which beta-lactam?

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.